~~<i id='E4F748F418'><strike id='E4F748F418'><tt id='E4F748F418'><pre id='E4F748F418'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

Wikipedia

author：explore 2025-09-30 16:24:11 - browse：4415

The Food and Drug Administration said on Friday that it has some safety concerns about an experimental CRISPR-based treatment for sickle cell disease, citing the methods used by its makers to evaluate the risk of inadvertently making unwanted changes to patients’ DNA.

None of the concerns raised by the FDA on Friday, however, suggest the agency is reluctant to approve the treatment, called exa-cel, which is being developed by Vertex Pharmaceuticals and CRISPR Therapeutics.

Exa-cel, given as a one-time infusion, uses CRISPR genome-editing technology to patch up the genetic faults at the root of sickle cell disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Doctor appointment wait times are getting worse

entertainment

hotspot

explore

hotspot

Wikipedia

SpencerPlatt/GettyImagesIn2004,thephysiciansearchfirmMerrittHawkinsfirstissuedtheirSurveyofPhysician

WSS

Brain 'hot spot' may explain why African Americans feel greater pain

4th of July breaks record for highest global temperature ever measured

Can food be medicine? And other questions about a new push

AI can decode, harness the power of the humane immune system

Why Charlie Gard's case is so disturbing to Americans

When women are denied an abortion, their children fare worse than peers

explore

Wikipedia

entertainment

Drug repurposing or repositioning? The language matters

FDA panel signals lack of confidence in Amgen cancer drug data

Medical records are filled with copy

These geoengineering technologies could help combat the climate crisis, scientists say

Guidelines to prevent youth baseball injuries need more muscle

Phenylephrine and the overlooked value of the placebo effect

Sports medicine is finally prioritizing gender equality

Doctor appointment wait times are getting worse

Guidelines to prevent youth baseball injuries need more muscle

7 people shot in DC, police say

entertainment

Brain 'hot spot' may explain why African Americans feel greater pain

Eli Lilly buys Point Biopharma in radiopharmaceuticals play

Australia's humpback populations rebound raising hopes of marine scientists

Can food be medicine? And other questions about a new push

When women are denied an abortion, their children fare worse than peers

Phenylephrine and the overlooked value of the placebo effect

hotspot

explore

hotspot

Wikipedia